Center for Medicare Advocacy: Drug Company Sues Medicare to Reverse Gains Being Made in Reining in Drug Costs
June 07, 2023
June 07, 2023
WILLIMANTIC, Connecticut, June 7 (TNStalk) -- The Center for Medicare Advocacy issued the following statement on June 6, 2023:
* * *
Today, pharmaceutical company Merck filed a lawsuit against the Medicare program in an effort to stop progress being made on drug pricing in Medicare through the Inflation Reduction Act (IRA), signed into law by President Biden in 2022.
Judy Stein, Executive Director of the Center for Medicare Advocacy, stated: "This is y . . .
* * *
Today, pharmaceutical company Merck filed a lawsuit against the Medicare program in an effort to stop progress being made on drug pricing in Medicare through the Inflation Reduction Act (IRA), signed into law by President Biden in 2022.
Judy Stein, Executive Director of the Center for Medicare Advocacy, stated: "This is y . . .